CCP team wins Translational Cancer Research Prize
The IBIS Team were awarded the 2014 Cancer Research UK Prize for Translational Cancer Research at the NCRI Cancer Conference in Liverpool in November.
The Translational Cancer Research Prize recognises the particular importance of scientists and doctors working together to translate laboratory discoveries into benefits for patients and the public.
Accepted by Professor Jack Cuzick and some of the team, theprize recognises the achievements of the IBIS-1 and IBIS-2 breast cancer prevention trials. These trials found taking preventive drugs such as tamoxifen and anastrozole can substantially reduce the risk of developing breast cancer in women at high risk of the disease.
The team said:
This is a great achievement for the IBIS trials and would not have been possible without the participation of all patients, past and present, of the IBIS-1 and IBIS-2 trials.